The EULAR Advanced Tissue Analysis initiative (ATAi) is a platform for learning – training – supporting – performing different experimental approaches aiming to understand the molecular basis of rheumatic and musculoskeletal disease (RMDs) and the development of new therapies. 

ATAi aims to:  
Develop a sharing and collaborating advanced tissue analysis technology community: research centres that are part of the EULAR ecosystem have already invested in many different technologies and platforms but will benefit from increased critical mass of expert research in a collaborative network setting.

Raise awareness of the potential and limitations of advanced tissue analysis technology to answer innovative RMD research questions by providing education, reference resources and expert hands-on training. 

Boost RMD research that leverages advanced tissue analysis technology (develop high-quality grant proposals, support accurate usage of the technology/methods leading to impactful research and publications) by applying the strengths of the new community towards the wider spectrum of EULAR countries’ RMD basic and translational research teams.

EULAR ATAi is driven by the EULAR Basic and Translational Research Sub-Committee, led by the chair, Prof. Rik Lories (Professor of Rheumatology, KU Leuven, Belgium).  

​See infographic​ 

The ATAi platform:  Supporting technologies for RMD tissue analysis

The EULAR Advanced Tissue Analysis initiative (ATAi) is a platform for learning – training – supporting – performing different experimental approaches aiming to understand the molecular basis of rheumatic and musculoskeletal disease (RMDs) and the development of new therapies.